Optimizing immunotherapy for colorectal cancer. Review uri icon

Overview

abstract

  • Important colorectal cancer (CRC) studies in 2021, including a new standard of care for first-line treatment of MSI-H–dMMR metastatic CRC, single-cell and spatial analysis of primary tumours and investigations of diet in preclinical models of cancer initiation, have provided novel insights into the CRC immune microenvironment.

publication date

  • February 1, 2022

Research

keywords

  • Colorectal Neoplasms
  • Immunotherapy
  • Tumor Microenvironment

Identity

PubMed Central ID

  • PMC9487162

Scopus Document Identifier

  • 85121350020

Digital Object Identifier (DOI)

  • 10.1038/s41575-021-00569-4

PubMed ID

  • 34907331

Additional Document Info

volume

  • 19

issue

  • 2